PNH and aHUS Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The PNH and aHUS Market was anticipated to grow from US$ 4855 million in 2020 to US$ 7023 million by 2028; it is expected to grow at a CAGR of 5% during the forecast period 2022–2028.

Paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are both sporadic and hereditary disorders. In PNH, the destruction of red blood cells in humans occurs much earlier than expected. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are produced in the bone marrow and ultimately turn into red blood cells, white blood cells, and platelets. People with PNH have some defective hematopoietic cells that produce defective red blood cells. These damaged cells are very vulnerable to premature destruction by the whole system. HUS is a disease in which blood clots form in small blood vessels throughout the body.

Market Segments

By Type

• Soliris
• Ultomiris

By Application

• PNH
• aHUS

Key Players

•  Alexion Pharmaceuticals
•  Akari Therapeutics
•  Apellis Pharmaceuticals
•  Incyte Corp
•  Achillion Pharmaceuticals Inc
•  Amgen Inc
•  ChemoCentryx Inc
•  Vertex Pharmaceuticals
•  United Therapeutics
•  Omeros Corp

Scope of the Report

The research study analyzes the global PNH and aHUS industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by PNH and aHUS Market Report

1. What was the PNH and aHUS Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of PNH and aHUS Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the PNH and aHUS Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.